Trials / Sponsors / Kali Therapeutics, Inc.
Kali Therapeutics, Inc.
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A First-in-human Study of KT501 Administered Subcutaneously to Patients With Rheumatoid Arthritis (RA). Rheumatoid Arthritis (RA) | Phase 1 | 2026-03-06 |